| 1 |
27074555 | Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma. | 2016 May 17 |
4 |
| 2 |
25667457 | Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signaling. | 2015 Feb |
1 |
| 3 |
26438393 | Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch. | 2015 Oct 6 |
1 |
| 4 |
26623653 | The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways. | 2015 |
1 |
| 5 |
24980831 | Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals. | 2014 Jun 30 |
1 |
| 6 |
21750224 | Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo. | 2011 Sep |
1 |
| 7 |
20233973 | The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo. | 2010 Jun 3 |
2 |
| 8 |
18636153 | The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. | 2008 Aug |
1 |
| 9 |
16015388 | Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL+ human leukemia cells. | 2005 Sep |
1 |
| 10 |
14614324 | Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways. | 2003 Sep-Oct |
1 |